• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Northwest Biothrputcs Inc (OP:NWBO)

    0.1709 +0.0018 (+1.06%)
    Streaming Delayed Price Updated: 11:32 AM EDT, Jul 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Northwest Biothrputcs Inc

    BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Advances Delivery-Focused Oncology Platform Amid Growing Interest in Drug-Delivery Technologies
    Via Investor Brand Network
    Topics Artificial Intelligence Intellectual Property
    How Advanced Drug Delivery Could Improve Existing Cancer Treatments
    Via Investor Brand Network
    InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Targets CNS Drug Delivery Opportunity as Brain Therapeutics Innovation Accelerates
    Via Investor Brand Network
    Topics Intellectual Property
    Stocks to Watch in May 2023: FOBI.V / FOBIF, NWBO, ENZC, GEVI
    Via AB Newswire
    Topics Artificial Intelligence
    News headline image
    How Advanced Drug Delivery Could Improve Existing Cancer Treatments
    From BioMedWire
    Via GlobeNewswire
    News headline image
    Biotech Healthcare: CSDX, NWBO, BSEM, RDGL, NRXBF Emerging Stocks to Watch
    Via AB Newswire
    News headline image
    CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
    From BioMedWire
    Via GlobeNewswire
    12 OTC Stocks to Watch: Clean Vision Corporation (OTCQB: CLNV), NaturalShrimp Inc (OTCQB: SHMP), Northwest Biotherapeutics, Inc. (OTCQB: NWBO), and More
    Via AB Newswire
    Topics Intellectual Property
    Stock Market Surges “Milestones Reached”: SWISF / SKUR.C, NWBO, ENZC, ABML
    Via AB Newswire
    News headline image
    Cohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market Manipulation
    Via ACN Newswire
    Topics Law Enforcement Lawsuit
    News headline image
    NWBO Stock Alert: Northwest Bio Slams Citadel Securities in New Lawsuit ↗
    Shares of NWBO stock are rallying on Thursday, as Northwest Biotherapeutics sues a number of Wall Street firms for stock manipulation. 
    Via InvestorPlace
    News headline image
    A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know ↗
    While July gave markets around the world a breather, August reestablished 2022’s choppy financial conditions. 
    Via Benzinga
    News headline image
    These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month ↗
    The month of July saw $37.3 billion in trading volume for stocks that trade on the OTCQK and OTCQB. While some of the stocks that trade over-the-counter are considered penny stocks based on their share... 
    Via Benzinga
    News headline image
    Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June ↗
    Reflecting the expected conditions of a bear market, many of the world’s indices saw a decrease in price throughout June. 
    Via Benzinga
    News headline image
    The OTC Markets' Most-Active Securities Embrace International Operators As Volatility Envelops Markets In May ↗
    Reflecting the world’s uncertainty about the U.S. economy, the market’s major indices saw incredible volatility in May. 
    Via Benzinga
    News headline image
    If You Invested $1000 In Northwest Biotherapeutics 5 Years Ago, Here's How Much You Would Have Today ↗
    Northwest Biotherapeutics (OTC:NWBO) has outperformed the market over the past 5 years by 42.99% on an annualized basis producing an average annual return of 54.57%. Currently, Northwest... 
    Via Benzinga
    News headline image
    Northwest Biotherapeutics, Inc. (OTC:NWBO) Investor Notice: Investigation over Potential Wrongdoing ↗
    San Diego, CA -- (SBWIRE) -- 04/28/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Northwest Biotherapeutics, Inc. 
    Via SBWire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.